Impact of Comorbidities on the Severity of Disease & Outcome in Children with COVID 19 at a Tertiary Care Pediatric Hospital, Rawalpindi.

Introduction: Coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was initially identified in Wuhan, China, in December 2019. The virus affects almost all countries of the world. It has infected humans in all age groups, of all ethnicities, both males and females. It is consi...

Full description

Saved in:
Bibliographic Details
Main Authors: Rai Muhammad Asghar, Muddassar Sharif, Khalid Saheel, Isfandyar Khan, Abid Hussain, Rai Rijjal Ashraf
Format: Article
Language:English
Published: Rawalpindi Medical University 2023-06-01
Series:Journal of Rawalpindi Medical College
Online Access:https://www.journalrmc.com/index.php/JRMC/article/view/1954
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832086937190531072
author Rai Muhammad Asghar
Muddassar Sharif
Khalid Saheel
Isfandyar Khan
Abid Hussain
Rai Rijjal Ashraf
author_facet Rai Muhammad Asghar
Muddassar Sharif
Khalid Saheel
Isfandyar Khan
Abid Hussain
Rai Rijjal Ashraf
author_sort Rai Muhammad Asghar
collection DOAJ
description Introduction: Coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was initially identified in Wuhan, China, in December 2019. The virus affects almost all countries of the world. It has infected humans in all age groups, of all ethnicities, both males and females. It is considered that COVID-19, in those with underlying health conditions or co-morbidities, has an increasingly rapid and severe progression, often leading to death. This study is designed to evaluate the impact of co-morbidities on the severity and outcome of COVID-19 infection in children. Methods: This retrospective observational study was conducted at the pediatric department, Benazir Bhutto Hospital Rawalpindi from March 2020 to September 2021. Every confirmed COVID-19 admitted case according to inclusion criteria was enrolled for the study. Data were retrieved from hospital records; data was recorded on a predesigned study questionnaire, entered and analyzed in SPSS version 24 for descriptive statistics and bivariate analysis. Results: 109 children were enrolled with confirmed COVID-19, of these 64(58.7%) were males and 45(41.2%) were females. The age of the patients ranged from infants to 12 years with a mean age of 27.25 months. Comorbidities were present in 70 patients     (64.2%).CHD was the most common co-morbid condition (n=18, 16.5%). Most of the patients experienced mild to moderate symptoms (n=64.2%) while severe symptoms were found in (n=35.8%) patients. 27 patients (24.8%) required Ventilatory support, and of these 20 patients (18.3%) had underlying co-morbidity. The total number of patients who expired was 27(24.7%), and 30.3% of patients who expired had co-morbid conditions. the patients with co-morbid conditions had a longer stay in the hospital. 35 patients (32.1%)with underlying co-morbidity remained admitted for more than a week and 13 patients(9%)for more than two weeks. Conclusion: Pediatric patients with co-morbidities have a higher risk of severe COVID-19 and associated mortality than children without underlying disease. Children with underlying conditions need to be carefully assessed and closely monitored. Further data are required to define these associations and adequate guidelines to manage high-risk children with COVID-19. Keywords: Coronavirus, COVID-19, Pediatrics, Co-morbidity, Severity, Outcome
format Article
id doaj-art-6d8a8afe369b4ae295246fc47a7d6a64
institution Kabale University
issn 1683-3562
1683-3570
language English
publishDate 2023-06-01
publisher Rawalpindi Medical University
record_format Article
series Journal of Rawalpindi Medical College
spelling doaj-art-6d8a8afe369b4ae295246fc47a7d6a642025-02-06T08:43:14ZengRawalpindi Medical UniversityJournal of Rawalpindi Medical College1683-35621683-35702023-06-0127210.37939/jrmc.v27i2.1954Impact of Comorbidities on the Severity of Disease & Outcome in Children with COVID 19 at a Tertiary Care Pediatric Hospital, Rawalpindi.Rai Muhammad AsgharMuddassar SharifKhalid SaheelIsfandyar KhanAbid HussainRai Rijjal Ashraf Introduction: Coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was initially identified in Wuhan, China, in December 2019. The virus affects almost all countries of the world. It has infected humans in all age groups, of all ethnicities, both males and females. It is considered that COVID-19, in those with underlying health conditions or co-morbidities, has an increasingly rapid and severe progression, often leading to death. This study is designed to evaluate the impact of co-morbidities on the severity and outcome of COVID-19 infection in children. Methods: This retrospective observational study was conducted at the pediatric department, Benazir Bhutto Hospital Rawalpindi from March 2020 to September 2021. Every confirmed COVID-19 admitted case according to inclusion criteria was enrolled for the study. Data were retrieved from hospital records; data was recorded on a predesigned study questionnaire, entered and analyzed in SPSS version 24 for descriptive statistics and bivariate analysis. Results: 109 children were enrolled with confirmed COVID-19, of these 64(58.7%) were males and 45(41.2%) were females. The age of the patients ranged from infants to 12 years with a mean age of 27.25 months. Comorbidities were present in 70 patients     (64.2%).CHD was the most common co-morbid condition (n=18, 16.5%). Most of the patients experienced mild to moderate symptoms (n=64.2%) while severe symptoms were found in (n=35.8%) patients. 27 patients (24.8%) required Ventilatory support, and of these 20 patients (18.3%) had underlying co-morbidity. The total number of patients who expired was 27(24.7%), and 30.3% of patients who expired had co-morbid conditions. the patients with co-morbid conditions had a longer stay in the hospital. 35 patients (32.1%)with underlying co-morbidity remained admitted for more than a week and 13 patients(9%)for more than two weeks. Conclusion: Pediatric patients with co-morbidities have a higher risk of severe COVID-19 and associated mortality than children without underlying disease. Children with underlying conditions need to be carefully assessed and closely monitored. Further data are required to define these associations and adequate guidelines to manage high-risk children with COVID-19. Keywords: Coronavirus, COVID-19, Pediatrics, Co-morbidity, Severity, Outcome https://www.journalrmc.com/index.php/JRMC/article/view/1954
spellingShingle Rai Muhammad Asghar
Muddassar Sharif
Khalid Saheel
Isfandyar Khan
Abid Hussain
Rai Rijjal Ashraf
Impact of Comorbidities on the Severity of Disease & Outcome in Children with COVID 19 at a Tertiary Care Pediatric Hospital, Rawalpindi.
Journal of Rawalpindi Medical College
title Impact of Comorbidities on the Severity of Disease & Outcome in Children with COVID 19 at a Tertiary Care Pediatric Hospital, Rawalpindi.
title_full Impact of Comorbidities on the Severity of Disease & Outcome in Children with COVID 19 at a Tertiary Care Pediatric Hospital, Rawalpindi.
title_fullStr Impact of Comorbidities on the Severity of Disease & Outcome in Children with COVID 19 at a Tertiary Care Pediatric Hospital, Rawalpindi.
title_full_unstemmed Impact of Comorbidities on the Severity of Disease & Outcome in Children with COVID 19 at a Tertiary Care Pediatric Hospital, Rawalpindi.
title_short Impact of Comorbidities on the Severity of Disease & Outcome in Children with COVID 19 at a Tertiary Care Pediatric Hospital, Rawalpindi.
title_sort impact of comorbidities on the severity of disease outcome in children with covid 19 at a tertiary care pediatric hospital rawalpindi
url https://www.journalrmc.com/index.php/JRMC/article/view/1954
work_keys_str_mv AT raimuhammadasghar impactofcomorbiditiesontheseverityofdiseaseoutcomeinchildrenwithcovid19atatertiarycarepediatrichospitalrawalpindi
AT muddassarsharif impactofcomorbiditiesontheseverityofdiseaseoutcomeinchildrenwithcovid19atatertiarycarepediatrichospitalrawalpindi
AT khalidsaheel impactofcomorbiditiesontheseverityofdiseaseoutcomeinchildrenwithcovid19atatertiarycarepediatrichospitalrawalpindi
AT isfandyarkhan impactofcomorbiditiesontheseverityofdiseaseoutcomeinchildrenwithcovid19atatertiarycarepediatrichospitalrawalpindi
AT abidhussain impactofcomorbiditiesontheseverityofdiseaseoutcomeinchildrenwithcovid19atatertiarycarepediatrichospitalrawalpindi
AT rairijjalashraf impactofcomorbiditiesontheseverityofdiseaseoutcomeinchildrenwithcovid19atatertiarycarepediatrichospitalrawalpindi